| Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net loss per share attributable to Common Stockholders (in
thousands, except share and per share data):
| | |
Three
Months
Ended | | |
Three
Months
Ended | |
| | |
September
30, 2025 | | |
September
30, 2024 | |
| Numerator: | |
| | |
| |
| Net
loss | |
$ | (22,192 | ) | |
$ | (2,497 | ) |
| Denominator: | |
| | | |
| | |
| Weighted
average shares used to computing basic and diluted net loss per share | |
| 423,081 | | |
| 25,844 | |
| Net
loss per share attributable to Common Stockholders - basic and diluted: | |
$ | (52.45 | ) | |
$ | (96.62 | ) |
| | |
Nine
Months
Ended | | |
Nine
Months
Ended | |
| | |
September
30, 2025 | | |
September
30, 2024 | |
| Numerator: | |
| | |
| |
| Net
loss | |
$ | (27,256 | ) | |
$ | (6,978 | ) |
| Denominator: | |
| | | |
| | |
| Weighted
average shares used to computing basic and diluted net loss per share | |
| 158,744 | | |
| 25,844 | |
| Net
loss per share attributable to Common Stockholders - basic and diluted: | |
$ | (171.70 | ) | |
$ | (270.00 | ) |
|
The
following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands,
except share and per share data):
| | |
Year
Ended December 31, 2024 | | |
Year
Ended December 31, 2023 | |
| Numerator: | |
| | |
| |
| Net
loss | |
$ | (9,230 | ) | |
$ | (10,281 | ) |
| Denominator: | |
| | | |
| | |
| Weighted
average shares used to computing basic and diluted net loss per share | |
| 25,844 | | |
| 25,827 | |
| Net
loss per share attributable to common stockholders – basic and diluted: | |
$ | (357.14 | ) | |
$ | (398.05 | ) |
|
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders |
The
following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable
to Common Stockholders for the periods presented because including them would have been antidilutive:
| | |
Three
Months
Ended | | |
Three
Months
Ended | |
| | |
September
30, 2025 | | |
September
30, 2024 | |
| Related
party convertible notes payable at fair value (1) | |
| - | | |
| - | |
| Loans
payable - related party at fair value (1) | |
| - | | |
| - | |
| Warrants | |
| 233,822 | | |
| - | |
| Options
to purchase Common Stock | |
| 20,845 | | |
| 13,705 | |
| Total | |
| 254,667 | | |
| 13,705 | |
| (1) | The Related party convertible notes and Loan’s payable - related party are convertible upon occurrence of various conversion scenarios. Therefore, the number of shares of Company Common Stock issuable upon their conversion is not currently estimable. |
| | |
Nine
Months Ended | |
| | |
September
30, 2025 | | |
September
30, 2024 | |
| Related
party convertible notes payable at fair value (1) | |
| - | | |
| - | |
| Loans
payable - related party at fair value (1) | |
| - | | |
| - | |
| Warrants | |
| 233,822 | | |
| - | |
| Options
to purchase Common Stock | |
| 20,845 | | |
| 13,705 | |
| Total | |
| 254,667 | | |
| 13,705 | |
|
The
following outstanding shares of potentially dilutive securities, as adjusted for the recapitalization and Reverse Stock Split (see Note
17) were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because
including them would have been antidilutive:
| | |
Years
ended December 31, | |
| | |
2024 | | |
2023 | |
| Convertible
preferred stock | |
| 82,377 | | |
| 82,377 | |
| Convertible
notes payable | |
| 15,510 | | |
| 10,384 | (1) |
| Convertible
loans | |
| - | (2) | |
| - | |
| Options
to purchase common stock | |
| 13,705 | | |
| 13,751 | |
| Total | |
| 111,592 | | |
| 106,512 | |
| (1) | The conversion of the Convertible Notes and Senior Notes to common stock is dependent on the price of SPAC transaction or other equity offering and the completion date of such offerings. These factors are not estimable, therefore, the number of common stock is not determinable. |
| (2) | The Tasly Convertible Notes issued between June and August 2023 and completed in February 2024 are convertible upon occurrence of various conversion scenarios. Therefore, the number of common stock shares issuable upon their conversion is not currently estimable. |
|